✨ Free AI Report
ARROWHEAD PHARMACEUTICALS, INC.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research ARROWHEAD PHARMACEUTICALS, INC.
Company Research

ARROWHEAD PHARMACEUTICALS, INC.: Business Overview, Financials & Competitive Analysis

Arrowhead Pharmaceuticals, Inc. is a trailblazer in the biotechnology industry, specializing in RNA interference (RNAi) therapeutics. Founded in 1989 and headquartered in Pasadena, California, the...

Analyst-debate audio for ARROWHEAD PHARMACEUTICALS, INC.

AskCyborg analysts argue the bull and bear cases for ARROWHEAD PHARMACEUTICALS, INC. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Company OverviewProduct PortfolioLeadership and Management TeamFinancial OverviewMarketing StrategiesMarket Overview and Competitors
Get Interactive Report Freeor start reading below
Live on AskCyborg
7/10Strong
Arrowhead Pharmaceuticals, Inc.

Pioneering RNAi therapeutic company achieving first commercial approval milestone with strong cash position and validated Novartis partnership, positioned for cardiometabolic...

▶︎ Listen to the 90-second analyst debate
7/ 10Strong

Cyborg Score thesis

Pioneering RNAi therapeutic company achieving first commercial approval milestone with strong cash position and validated...

Read the full analyst-debate transcript →
Industry Biotechnology / RNA Therapeutics
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 16, 2026
AI-Generated Research
30+ Page Report

Get the Latest ARROWHEAD PHARMACEUTICALS, INC. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Arrowhead Pharmaceuticals, Inc. is a trailblazer in the biotechnology industry, specializing in RNA interference (RNAi) therapeutics. Founded in 1989 and headquartered in Pasadena, California, the company is driven by a mission to develop innovative medicines that treat intractable diseases by silencing the genes that cause them. Arrowhead has a diverse and continually expanding portfolio of drug candidates, focusing on liver diseases, respiratory diseases, and other critical conditions.

Company Overview

Pro stress-test →

Arrowhead Pharmaceuticals, Inc. has emerged as a leader in the biotechnology sector. With a focus on RNA interference (RNAi) technology, the company has developed a suite of therapies targeting a range of diseases. Arrowhead’s core mission is to leverage this groundbreaking technology to create treatments for conditions that were previously considered untreatable.

Product Portfolio

Pro stress-test →

Arrowhead’s product portfolio is both extensive and innovative. The company has several RNAi-based investigational drug candidates in various stages of clinical development. Key products include:

  • ARO-AAT: Targeting liver disease associated with alpha-1 antitrypsin deficiency.
  • ARO-HBV: Aimed at chronic hepatitis B virus infection.
  • ARO-ENaC: Focused on cystic fibrosis and other pulmonary diseases.
  • ARO-APOC3: Designed for hypertriglyceridemia and cardiovascular diseases.

Leadership and Management Team

Pro stress-test →

The leadership team at Arrowhead Pharmaceuticals, Inc. is composed of experienced professionals with a strong background in biotechnology and pharmaceutical development. Key members include:

  • Christopher Anzalone, Ph.D. – President and CEO
  • Bruce Given, M.D. – Chief Operating Officer
  • James Hamilton, M.D., MBA – Chief Development Officer
  • David Lewis, Ph.D. – Chief Scientific Officer

Financial Overview

Arrowhead Pharmaceuticals, Inc. has shown robust financial performance, with consistent growth in revenue and a strong balance sheet. Key financial metrics include:

  • Revenue: $87.9 million in 2022
  • Market Capitalization: Approximately $3 billion
  • R&D Investment: Over $100 million annually

Marketing Strategies

Arrowhead employs a multi-faceted marketing strategy that includes:

  • Strategic partnerships and collaborations with leading pharmaceutical companies.
  • Active participation in scientific conferences and industry events.
  • Utilizing digital platforms for targeted outreach and engagement.

Market Overview and Competitors

The biotechnology market is highly competitive, with numerous players striving for innovation. Key competitors of Arrowhead Pharmaceuticals, Inc. include:

  • Alnylam Pharmaceuticals
  • Ionis Pharmaceuticals
  • Regeneron Pharmaceuticals
  • Moderna Therapeutics

Sales Strategies

Arrowhead’s sales strategies focus on:

  • Building strong relationships with healthcare providers and institutions.
  • Leveraging clinical data to demonstrate the efficacy of their therapies.
  • Expanding their global footprint through strategic alliances.

Technologies Utilized

Arrowhead is at the forefront of RNAi technology, utilizing advanced delivery systems such as:

  • Targeted RNAi Molecules
  • TRIM-Away technology for targeted protein degradation
  • Subcutaneous delivery platforms

HR Practices

Arrowhead Pharmaceuticals, Inc. is committed to fostering a collaborative and inclusive work environment. Key HR practices include:

  • Comprehensive employee training and development programs.
  • Competitive compensation and benefits packages.
  • Initiatives to promote diversity and inclusion within the workplace.

Corporate Responsibility

Arrowhead takes its corporate social responsibility seriously, with initiatives such as:

  • Environmental sustainability programs.
  • Community outreach and education efforts.
  • Ethical business practices and transparency.

Future Plans

Looking ahead, Arrowhead Pharmaceuticals, Inc. is poised for growth with plans to:

  • Expand its pipeline of RNAi therapeutics.
  • Enter new therapeutic areas and markets.
  • Continue to invest in cutting-edge research and development.

Get the comprehensive report on ARROWHEAD PHARMACEUTICALS, INC. by subscribing

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on ARROWHEAD PHARMACEUTICALS, INC..

+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when ARROWHEAD PHARMACEUTICALS, INC. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare ARROWHEAD PHARMACEUTICALS, INC. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

ARROWHEAD PHARMACEUTICALS, INC. operates in Biotechnology / RNA Therapeutics. See how the rest of the sector scores on the Cyborg framework.

Top companies in Biotechnology by Cyborg Score

Browse Biotechnology / RNA Therapeutics research →
NEW · MCP server

Ask your AI assistant about ARROWHEAD PHARMACEUTICALS, INC.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare ARROWHEAD PHARMACEUTICALS, INC. and its top competitor on Cyborg Score”
“What did ARROWHEAD PHARMACEUTICALS, INC. do this quarter?”
“Is ARROWHEAD PHARMACEUTICALS, INC. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does ARROWHEAD PHARMACEUTICALS, INC. do?+
Arrowhead Pharmaceuticals, Inc. is a trailblazer in the biotechnology industry, specializing in RNA interference (RNAi) therapeutics. Founded in 1989 and headquartered in Pasadena, California, the...
What is ARROWHEAD PHARMACEUTICALS, INC.'s Cyborg Score?+
ARROWHEAD PHARMACEUTICALS, INC. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are ARROWHEAD PHARMACEUTICALS, INC.'s main competitors?+
Named competitors include Onpattro, Leqvio, WVE programs. The full competitive landscape is in the AskCyborg report.
How can I get the full ARROWHEAD PHARMACEUTICALS, INC. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the ARROWHEAD PHARMACEUTICALS, INC. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track ARROWHEAD PHARMACEUTICALS, INC. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Company Research

Gambling and Lotteries Industry BriefingStationery and Office Products Industry BriefingDefense Tech Industry BriefingAi Infrastructure Systems Industry BriefingPet Insurance Industry BriefingSelf-Storage Industry BriefingMetal Additive Manufacturing Industry BriefingAi Accelerator Hardware Systems Industry BriefingLuxury Wines & Spirits Industry BriefingEnzymatic Plastic Recycling Industry BriefingInfrastructure as a Service (IaaS) Industry Briefingluxury fashion apparel Industry Briefing

Explore Industry Research

Travel Insurance Industry Company Research ReportSecurity Services Industry Company Research ReportLandscaping and Grounds Maintenance Industry Company Research ReportJanitorial and Cleaning Services Industry Company Research ReportSustainability Consulting Industry Company Research ReportReal Estate Investment Trusts (REITs) Industry Company Research Report
Browse All Company ResearchBrowse All Industry ResearchRSS Feed